Use of Actigraphy to Measure Symptoms of Agitation in Dementia.


Journal

The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry
ISSN: 1545-7214
Titre abrégé: Am J Geriatr Psychiatry
Pays: England
ID NLM: 9309609

Informations de publication

Date de publication:
08 2019
Historique:
received: 11 12 2018
revised: 21 02 2019
accepted: 22 02 2019
pubmed: 7 4 2019
medline: 29 8 2020
entrez: 7 4 2019
Statut: ppublish

Résumé

To evaluate the feasibility and validity of actigraphy as a measurement of agitation in dementia. Participants aged 65 and older, diagnosed with dementia, residing in a geriatric psychiatry inpatient unit or long-term care facility were included in a cross-sectional study. Agitation was assessed using the Cohen-Mansfield Agitation Inventory (CMAI) and the Neuropsychiatric Inventory (NPI). Actigraphy was measured over seven days and compared across groups categorized as low or high agitation based on a CMAI cutoff score of 50. Twenty participants were enrolled (mean age = 74.3 years, standard deviation [SD] = 8.69). The 24-hour mean motor activity as measured with actigraphy was significantly different between the low and high agitation groups (180.23, SD = 86.34 versus 81.51, SD = 30.29, Z = 2.29; p = 0.02). Most actigraph variables had significant correlations with CMAI and NPI scores. Actigraphy was highly correlated with informant-based methods for measuring agitation in individuals with dementia and actigraphy may be useful tool for measuring agitation.

Identifiants

pubmed: 30952608
pii: S1064-7481(19)30266-0
doi: 10.1016/j.jagp.2019.02.013
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

865-869

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.

Auteurs

Amber Knuff (A)

Centre for Neuroscience Studies (AK, DPS), Queen's University, Kingston; Hamilton Health Sciences Centre (AK), Hamilton.

Roxanne H Leung (RH)

Department of Psychiatry (RHL, DPS), School of Medicine, Queen's University, Kingston.

Dallas P Seitz (DP)

Centre for Neuroscience Studies (AK, DPS), Queen's University, Kingston; Department of Psychiatry (RHL, DPS), School of Medicine, Queen's University, Kingston. Electronic address: seitzd@providencecare.ca.

Luljeta Pallaveshi (L)

Department of Psychiatry (LP, AMB), Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.

Amer M Burhan (AM)

Department of Psychiatry (LP, AMB), Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH